Tag: PDSB

Stock Earnings

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

PDS Biotechnology Corporation’s filing revealed that its Director Freitag Gregory Gene acquired Company’s shares for reported $25000.0 on Feb 28

Analysts Viewpoint

PDS Biotechnology Corporation’s recent filing unveils that its Director Freitag Gregory Gene acquired Company’s shares for reported $25000.0 on Feb

PDS Biotechnology Corporation (NASDAQ:PDSB) does about 682.76K shares in volume on a normal day but saw 403595 shares change hands